Comparison of combinations of Dexmedetomidine-Ketamine with propofol â??ketamine to put the children for Ct scan to sleep
Phase 3
- Conditions
- Health Condition 1: null- Children requiring CT sedation
- Registration Number
- CTRI/2015/04/005717
- Lead Sponsor
- Postgraduate Institute of Medical Education and resarch
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 120
Inclusion Criteria
Children requiring sedation for CT scan
Exclusion Criteria
ASA III-IV , respiratory compromise,drug allergy to study drugs,patient refusal
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Time to achieve full consciousness <br/ ><br>Timepoint: immediately on shifting to the recovery room and every 1 minute thereafter <br/ ><br>
- Secondary Outcome Measures
Name Time Method Onset of sedation ,Procedure time, Recovery time. <br/ ><br>A failed sedation,Hemodynamic changes during the procedure, incidence of occurrence of adverse effects and unwanted movements duringTimepoint: 4 hours postoperatively
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms by which Dexmedetomidine-Ketamine combination induces sedation in pediatric CT scans?
How does the efficacy of Dexmedetomidine-Ketamine compare to Propofol-Ketamine in pediatric sedation for CT scans?
What biomarkers are associated with optimal sedation response to Dexmedetomidine-Ketamine in children undergoing CT scans?
What are the potential adverse events and management strategies for Dexmedetomidine-Ketamine sedation in pediatric CT scans?
Are there alternative sedation regimens or competitor drugs for pediatric CT scans compared to Dexmedetomidine-Ketamine combinations?